• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Import Refusal Report

  • Print
  • Share
  • E-mail
-

Refusal Actions by FDA as Recorded in OASIS

for 61-Human and Animal Drugs


Entry/doc/line/sfx Refusal Date Product
Code
Manufacturer
FEI
Manufacturer
Name
Manufacturer
Country/Area
112-1197564-5/10/1 25-Oct-2002 61EDY09 3003671612 Eclipse Limited New Zealand
 
112-1168802-4/29/1 17-Oct-2002 61FCA61 3003206702 Pharma Exp Canada
 
582-0815469-0/1/1 01-Oct-2002 61FDC54 3003789860 SALEM SAXON LATIN AMERICA SD Costa Rica
 
WBA-9029054-4/1/1 21-Oct-2002 61HAY24 3003732568 D & O Group Exports India
 
112-1168802-4/16/1 17-Oct-2002 61HCA43 3003206702 Pharma Exp Canada
 
112-1169101-0/21/1 17-Oct-2002 61HCA43 3003206702 Pharma Exp Canada
 
112-1168802-4/17/1 17-Oct-2002 61JCA08 3003206702 Pharma Exp Canada
 
112-1169101-0/22/1 17-Oct-2002 61JCA08 3003206702 Pharma Exp Canada
 
112-1169101-0/23/1 17-Oct-2002 61JCA08 3003206702 Pharma Exp Canada
 
112-1169101-0/24/1 17-Oct-2002 61JCA08 3003206702 Pharma Exp Canada
 
112-1175085-7/4/1 17-Oct-2002 61JCA08 3003671612 Eclipse Limited New Zealand
 
112-1175085-7/5/1 17-Oct-2002 61JCA08 3003671612 Eclipse Limited New Zealand
 
112-1175085-7/6/1 17-Oct-2002 61JCA08 3003671612 Eclipse Limited New Zealand
 
112-1168802-4/21/1 17-Oct-2002 61JCA13 3003206702 Pharma Exp Canada
 
112-1169101-0/34/1 17-Oct-2002 61JCA13 3003206702 Pharma Exp Canada
 
112-1168802-4/15/1 17-Oct-2002 61JCE10 3003206702 Pharma Exp Canada
 
112-1169101-0/20/1 17-Oct-2002 61JCE10 3003206702 Pharma Exp Canada
 
112-1209412-3/1/1 24-Oct-2002 61JCY14 3003804131 Cousin Evelyne Guadeloupe
 
112-1209412-3/2/1 24-Oct-2002 61JCY14 3003804131 Cousin Evelyne Guadeloupe
 
112-1197564-5/4/1 25-Oct-2002 61JDY08 3003671612 Eclipse Limited New Zealand
 
112-1197564-5/5/1 25-Oct-2002 61JDY08 3003671612 Eclipse Limited New Zealand
 
112-1197564-5/6/1 25-Oct-2002 61JDY08 3003671612 Eclipse Limited New Zealand
 
112-1209412-3/3/1 24-Oct-2002 61JDY10 3003804131 Cousin Evelyne Guadeloupe
 
336-9957646-0/1/1 30-Oct-2002 61KCS27 3001175063 Boehringer Ingelheim Backmittel Gmbh Germany
 
112-1169101-0/33/1 17-Oct-2002 61LCA38 3003206702 Pharma Exp Canada
 
F11-3570471-8/1/1 02-Oct-2002 61LDU08 3003074214 Biesterfeld Siemsgluss Germany
 
112-1168802-4/19/1 17-Oct-2002 61MCA99 3003206702 Pharma Exp Canada
 
112-1169101-0/27/1 17-Oct-2002 61MCA99 3003206702 Pharma Exp Canada
 
112-1169101-0/28/1 17-Oct-2002 61MCA99 3003206702 Pharma Exp Canada
 
112-1168802-4/26/1 17-Oct-2002 61NAA03 3003206702 Pharma Exp Canada
 
112-1169101-0/39/1 17-Oct-2002 61NAA03 3003206702 Pharma Exp Canada
 
112-1169101-0/40/1 17-Oct-2002 61NAA03 3003206702 Pharma Exp Canada
 
112-1168802-4/24/1 17-Oct-2002 61NCA73 3003206702 Pharma Exp Canada
 
112-1169101-0/38/1 17-Oct-2002 61NCA73 3003206702 Pharma Exp Canada
 
112-1168802-4/27/1 17-Oct-2002 61NCA75 3003206702 Pharma Exp Canada
 
112-1169101-0/41/1 17-Oct-2002 61NCA75 3003206702 Pharma Exp Canada
 
112-1169101-0/42/1 17-Oct-2002 61NCA75 3003206702 Pharma Exp Canada
 
112-0997227-3/1/1 01-Oct-2002 61NCA76 1000164638 Merck Sharp & Dohme-Chibret Switzerland
 
112-1168802-4/20/1 17-Oct-2002 61NCA77 3003206702 Pharma Exp Canada
 
112-1169101-0/29/1 17-Oct-2002 61NCA77 3003206702 Pharma Exp Canada
 
112-1169101-0/30/1 17-Oct-2002 61NCA77 3003206702 Pharma Exp Canada
 
112-1169101-0/31/1 17-Oct-2002 61NCA77 3003206702 Pharma Exp Canada
 
112-1169101-0/32/1 17-Oct-2002 61NCA77 3003206702 Pharma Exp Canada
 
112-1168802-4/32/1 17-Oct-2002 61NCB05 3003206702 Pharma Exp Canada
 
112-1169101-0/47/1 17-Oct-2002 61NCB05 3003206702 Pharma Exp Canada
 
DQ4-8999520-8/1/1 01-Oct-2002 61NCB76 3003601081 Smithkline Beecham Canada
 
XXX-0051548-7/1/1 03-Oct-2002 61NCB76 3002871441 Smith Kline Beecham Mexico Mexico
 
112-1168802-4/11/1 17-Oct-2002 61NCF80 3003206702 Pharma Exp Canada
 
112-1168802-4/12/1 17-Oct-2002 61NCF80 3003206702 Pharma Exp Canada
 
112-1169101-0/18/1 17-Oct-2002 61NCF80 3003206702 Pharma Exp Canada
 
112-1169101-0/19/1 17-Oct-2002 61NCF80 3003206702 Pharma Exp Canada
 
112-1168802-4/3/1 17-Oct-2002 61PCA99 3003206702 Pharma Exp Canada
 
112-1168802-4/5/1 17-Oct-2002 61PCA99 3003206702 Pharma Exp Canada
 
112-1169101-0/6/1 17-Oct-2002 61PCA99 3003206702 Pharma Exp Canada
 
112-1169101-0/8/1 17-Oct-2002 61PCA99 3003206702 Pharma Exp Canada
 
112-1169101-0/9/1 17-Oct-2002 61PCA99 3003206702 Pharma Exp Canada
 
144-2000512-8/1/1 29-Oct-2002 61RDS99 3002438072 Olaine Chemical Pharmaceutical Latvia
 
112-1063392-2/1/1 11-Oct-2002 61SCY99 3003764195 Jughal Kishore India
 
112-1063392-2/2/1 11-Oct-2002 61SCY99 3003764195 Jughal Kishore India
 
112-1168802-4/28/1 17-Oct-2002 61WCA46 3003206702 Pharma Exp Canada
 
112-1169101-0/43/1 17-Oct-2002 61WCA46 3003206702 Pharma Exp Canada
 
112-1221299-8/9/1 28-Oct-2002 61WCF45 3003806817 Minerva Corporation United Kingdom
 
MH4-9501063-8/25/1 07-Oct-2002 61XAW14 1000168130 Merck Sharp & Dohme Limited United Kingdom
 
-
-